We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant

Delisted

TROVW was delisted on the 30th of May, 2017.

4 hedge funds and large institutions have $2.06M invested in TrovaGene, Inc. Warrant in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more capital invested

Capital invested by funds: $1.54M → $2.06M (+$520K)

33% more funds holding

Funds holding: 34 (+1)

12% less call options, than puts

Call options by funds: $93K | Put options by funds: $106K

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
Calls
$93K
Puts
$106K
Net Calls
-$13K
Net Calls Change
-$1.41M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$34.3K
2
Morgan Stanley
Morgan Stanley
New York
-$4.7K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$2.04M -$34.3K -10,600 -2%
Morgan Stanley
2
Morgan Stanley
New York
$13K -$4.7K -1,452 -31%
TRCT
3
Tower Research Capital (TRC)
New York
$1K +$525 +162 +81%
UBS Group
4
UBS Group
Switzerland
+$324 +100 New

TROVW Hedge Fund Activity: Q1 2016 in Review

4 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q1 2016, worth a combined $2.06M — up 34% from $1.54M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new TROVW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $525. The largest seller was Millennium Management, cutting an estimated $34.3K.

  • 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q1 2016, up from 3 in Q4 2015.
  • Funds reported $2.06M of TrovaGene, Inc. Warrant stock for Q1 2016, up 34% quarter-over-quarter.
  • 1 fund opened new TrovaGene, Inc. Warrant positions in Q1 2016 and 0 closed out, a net change of +1 holder.
  • The largest TrovaGene, Inc. Warrant buyer in Q1 2016 was Tower Research Capital (TRC), an estimated $525 added.
  • The largest TrovaGene, Inc. Warrant seller in Q1 2016 was Millennium Management, an estimated $34.3K sold.

Based on aggregated 13F filings for Q1 2016.